{"DataElement":{"publicId":"2182016","version":"1","preferredName":"Agent Protocol Total Dose","preferredDefinition":"The total protocol dose of drugs for this cycle.","longName":"AGT_PROT_TTL_DOSE","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2182015","version":"1","preferredName":"Agent Protocol","preferredDefinition":"the drug agent used for the protocol.","longName":"AGT_PROT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2223333","version":"1","preferredName":"Agent","preferredDefinition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect. (NCI)","longName":"C1708","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Agent","conceptCode":"C1708","definition":"An active power or cause (as principle, substance, physical or biological factor, etc.) that produces a specific effect.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F62B10F2-76A7-2830-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-05-02","endDate":null,"createdBy":"UMLLOADER","dateCreated":"2005-05-02","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2177383","version":"1","preferredName":"Protocol","preferredDefinition":"An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.","longName":"Protocol","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE29A78C-526A-3A05-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-10-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2002-10-29","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D5FE454A-7465-5F54-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-19","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Use caBIG NCIt based OC instead. - dw","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2188705","version":"1","preferredName":"Agent Total Dose","preferredDefinition":"the total dose of an agent.","longName":"AGT_TTL_DOSE","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"10","minValue":null,"maxValue":null,"decimalPlace":"2","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008560","version":"1","preferredName":"Therapy Doses","preferredDefinition":"quantities of therapy or treatment.","longName":"TX_DOSES","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B30C55B6-50B5-1219-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-30","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-30","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2207921","version":"1","preferredName":"Total Dose","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:The amount of medicine taken, or radiation given, at one time.","longName":"C25304:C25488","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Dose","conceptCode":"C25488","definition":"A quantity of an agent (such as substance or energy) administered, taken, or absorbed at one time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3542-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E53FB579-C11C-0A0E-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-09-29","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-09-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"12173174","version":"1","longName":"PCDC Aggregated Dictionary","context":"Pediatric Cancer","ClassificationSchemeItems":[{"publicId":"12173201","version":"1","longName":"Medications","context":"Pediatric Cancer"},{"publicId":"12173179","version":"1","longName":"Treatment","context":"Pediatric Cancer"}]}],"AlternateNames":[{"name":"AGT_PROT_TTL_DOSE","type":"USED_BY","context":"CTEP"},{"name":"5-FU_ECDOSE","type":"OID, AMC","context":"AMC"},{"name":"MITOMYCIN-C_ECDOSE","type":"OID, AMC","context":"AMC"},{"name":"ABTC","type":"USED_BY","context":"ABTC"},{"name":"AMC","type":"USED_BY","context":"AMC"},{"name":"NIVOLUMAB_ECDOSE","type":"OID, AMC","context":"AMC"},{"name":"TOTAL_DOSE_ADMINISTERED","type":"PCDC Alt Name","context":"Pediatric Cancer"}],"ReferenceDocuments":[{"name":"Total Protocol Dose of Agents","type":"Preferred Question Text","description":"Total Protocol Dose of Agents/Drugs for this cycle","url":null,"context":"CTEP"},{"name":"COG_CRF_TEXT_1","type":"Alternate Question Text","description":"Total dose of investigational agent during the reporting period","url":null,"context":"CTEP"},{"name":"ABTC 1601","type":"Alternate Question Text","description":"Total protocol dose","url":null,"context":"ABTC"},{"name":"AMC Question Text 3","type":"Alternate Question Text","description":"Total administered dose of 5-FU","url":null,"context":"AMC"},{"name":"AMC Question Text 2","type":"Alternate Question Text","description":"Total administered dose of Mitomycin-C","url":null,"context":"AMC"}],"origin":"Brain CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"D5FE67AC-89ED-5F5C-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2004-03-19","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-03-19","modifiedBy":"JKNABLE","dateModified":"2023-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}